This brand name is authorized in Cyprus
The drug HEMAFER FOL contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Ferric hydroxide polymaltose complex
UNII 2UA751211N - FERRIC HYDROXIDE
|
|
|
|
2
Folic acid
UNII 935E97BOY8 - FOLIC ACID
|
|
Folic acid is a member of the vitamin B group which is reduced in the body to tetrahydrofolate, a co-enzyme active in several metabolic processes and produces a haemopoietic response in nutritional megaloblastic anaemias. Folic acid is rapidly absorbed and widely distributed in body tissues. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B03AB | Iron trivalent, oral preparations | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations |
| B03AD | Iron in combination with folic acid | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations |
| B03AD04 | Ferric oxide polymaltose complexes and folic acid | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AD Iron in combination with folic acid |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
